Cite

HARVARD Citation

    Idbaih, A. et al. (n.d.). PL02.1.A EO2401, a novel microbiome-derived therapeutic vaccine for patients with recurrent glioblastoma: ROSALIE study. Neuro-oncology. p. ii2. [Online]. 
  
Back to record